Cargando…
LB19. Intramuscular therapeutic immunization targeting Rel(Mtb)/MIP-3 induces immune signatures associated with better TB control in vivo compared to
BACKGROUND: Tuberculosis (TB) is one of the leading causes of death from a single infectious agent worldwide. The lengthy treatment regimen reflects the unique ability of a subpopulation of “persister” bacteria to remain in a nonreplicating state in the infected host through various adaptive strateg...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644433/ http://dx.doi.org/10.1093/ofid/ofab466.1655 |